PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE ™ ...
<0> CovidienLynn Phillips, 314-654-3263Manager, Media RelationsPharmaceuticalsorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor RelationsorStephen Littlejohn ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
MISSISSAUGA, ON, Aug. 5, 2025 /CNW/ - Kye Pharmaceuticals Inc. ("Kye"), a leading Canadian-based commercial-stage specialty pharmaceutical company focused on licensing and commercializing innovative ...
WASHINGTON, D.C. (WRIC) — Virginians who take morphine to manage pain are asked to check their bottles after a voluntary recall. Bryant Ranch Prepack, Inc. is voluntarily recalling one lot of 30mg ...
Eisai and Pfizer announced that the FDA has accepted for review the New Drug Application (NDA) for once-daily 23 mg Aricept (donepezil HCl extended release tablets) for the treatment of moderate to ...
AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of ...
New Delhi: Strides Pharma Science Ltd on Friday said its arm has received approval from the US health regulator for its generic version of Theophylline extended-release tablets indicated for ...
BRIDGEWATER, N.J., October 21, 2024--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company"), a global pharmaceutical company based in the U.S., today announced that ...
Zacks Investment Research on MSN
Pharvaris stock gains on HAE drug meeting late-stage study goals
Shares of Pharvaris PHVS rose nearly 22% on Wednesday after the company announced positive results from the phase III ...
FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents First once-daily nonstimulant to be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback